RxDoctor Payments Data

Jeffrey Collier, MD

Family Medicine · Carmel, INNPI 1942283833

Payments from drug & device makers

$2,053in general payments, 2019–2025

Across 136 payments — averaging $15.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$614
  • Novo Nordisk$411
  • Lilly USA, LLC$325
  • Takeda Pharmaceuticals U.S.A., Inc.$104
  • Bayer$90
  • Exact Sciences$59
  • plus $449 from 16 others

What the payments were for

  • Food & beverage$2,053100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,053 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$22,532
Medicare patients
144
Services billed
308

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban38$34,818
MounjaroTirzepatide30$29,321
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr58$29,056
JardianceEmpagliflozin26$24,485
OzempicSemaglutide23$21,953
MyrbetriqMirabegron17$11,041
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,122
Tresiba Flextouch U-200Insulin Degludec12$6,800
SynthroidLevothyroxine Sodium50$5,668
Dexlansoprazole DrDexlansoprazole15$1,938
Telmisartan106$1,922
Pravastatin Sodium151$1,806
Nebivolol Hcl25$1,800
Atorvastatin Calcium214$1,785
Felodipine ErFelodipine58$1,308

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKAnoro Ellipta, Trelegy Ellipta$25$36,17869 claims
PfizerEliquis$28$34,81838 claims
Lilly USA, LLCMounjaro$325$29,32130 claims
Boehringer IngelheimJardiance$17$24,48526 claims
Novo NordiskOzempic$411$21,95323 claims
Astellas Pharma US IncMyrbetriq$40$11,04117 claims
AbbVieSynthroid$614$5,66850 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →